J Bernhard1, J Aldridge2, P N Butow3, P Zoller4, R Brown5, A Smith6, I Juraskova7. 1. IBCSG Coordinating Center, Bern; Department of Medical Oncology, Inselspital, Bern University Hospital, Bern, Switzerland. Electronic address: juerg.bernhard@ibcsg.org. 2. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, USA. 3. School of Psychology, Centre for Medical Psychology and Evidence-based Decision-making (CeMPED); Psycho-Oncology Co-operative Research Group (PoCoG), University of Sydney, Sydney, Australia. 4. IBCSG Coordinating Center, Bern. 5. Department of Social and Behavioral Health, School of Medicine, Virginia Commonwealth University, Richmond, USA. 6. Psycho-Oncology Co-operative Research Group (PoCoG), University of Sydney, Sydney, Australia. 7. School of Psychology, Centre for Medical Psychology and Evidence-based Decision-making (CeMPED).
Abstract
BACKGROUND: The purpose was to investigate patient-doctor agreement on clinical trial discussion cross-culturally. METHODS: In the International Breast Cancer Study Group Trial 33-03 on shared decision-making for early breast cancer in Australian/New Zealand (ANZ) and Swiss/German/Austrian (SGA) centers, doctor and patient characteristics plus doctor stress and burnout were assessed. Within 2 weeks post-consultation about treatment options, the doctor and patient reported independently, whether a trial was discussed. Odds ratios of agreement for covariables were estimated by generalized estimating equations for each language cohort, with doctor as a random effect. RESULTS: In ANZ, 21 doctors and 339 patients were eligible; in SGA, 41 doctors and 427 patients. In cases where the doctor indicated 'no trial discussed', 82% of both ANZ and SGA patients agreed; if the doctor indicated 'trial discussed', 50% of ANZ and 38% of SGA patients agreed, respectively. Factors associated with higher agreement were: low tumor grade and fewer patients recruited into clinical trials in SGA; public institution, patient born in ANZ (versus other), higher doctor depersonalization and personal accomplishment in ANZ. CONCLUSION: There is discordance between oncologists and their patients regarding clinical trial discussion, particularly when the doctor indicates that a trial was discussed. Factors contributing to this agreement vary by culture.
BACKGROUND: The purpose was to investigate patient-doctor agreement on clinical trial discussion cross-culturally. METHODS: In the International Breast Cancer Study Group Trial 33-03 on shared decision-making for early breast cancer in Australian/New Zealand (ANZ) and Swiss/German/Austrian (SGA) centers, doctor and patient characteristics plus doctor stress and burnout were assessed. Within 2 weeks post-consultation about treatment options, the doctor and patient reported independently, whether a trial was discussed. Odds ratios of agreement for covariables were estimated by generalized estimating equations for each language cohort, with doctor as a random effect. RESULTS: In ANZ, 21 doctors and 339 patients were eligible; in SGA, 41 doctors and 427 patients. In cases where the doctor indicated 'no trial discussed', 82% of both ANZ and SGA patients agreed; if the doctor indicated 'trial discussed', 50% of ANZ and 38% of SGA patients agreed, respectively. Factors associated with higher agreement were: low tumor grade and fewer patients recruited into clinical trials in SGA; public institution, patient born in ANZ (versus other), higher doctor depersonalization and personal accomplishment in ANZ. CONCLUSION: There is discordance between oncologists and their patients regarding clinical trial discussion, particularly when the doctor indicates that a trial was discussed. Factors contributing to this agreement vary by culture.
Authors: M Holmes-Rovner; J Kroll; N Schmitt; D R Rovner; M L Breer; M L Rothert; G Padonu; G Talarczyk Journal: Med Decis Making Date: 1996 Jan-Mar Impact factor: 2.583
Authors: Jesse Jansen; Julia C M van Weert; Judith de Groot; Sandra van Dulmen; Thea J Heeren; Jozien M Bensing Journal: Patient Educ Couns Date: 2009-12-11
Authors: Jesse Jansen; Phyllis N Butow; Julia C M van Weert; Sandra van Dulmen; Rhonda J Devine; Thea J Heeren; Jozien M Bensing; Martin H N Tattersall Journal: J Clin Oncol Date: 2008-10-20 Impact factor: 44.544
Authors: Anne M H Todd; Barry J A Laird; Dorothy Boyle; Angela C Boyd; Lesley A Colvin; Marie T Fallon Journal: J Pain Symptom Manage Date: 2009-05-05 Impact factor: 3.612
Authors: Phyllis N Butow; Ming Sze; Priya Dugal-Beri; Michelle Mikhail; Maurice Eisenbruch; Michael Jefford; Penelope Schofield; Afaf Girgis; Madeleine King; David Goldstein Journal: Support Care Cancer Date: 2010-02-19 Impact factor: 3.603